Soluble guanylyl cyclase
Nakaki, T.
Nihon Rinsho. Japanese Journal of Clinical Medicine 58(Suppl 1): 230-234
2000
ISSN/ISBN: 0047-1852 PMID: 11026269 Document Number: 517135
Document emailed within 1 workday
Related Documents
Wu, C.C.; Chen, S.J.; Yen, M.H. 1998: Nitric oxide-independent activation of soluble guanylyl cyclase contributes to endotoxin shock in rats American Journal of Physiology 275(4): H1148-H1157Appleton, S.D.; Chretien, M.L.; McLaughlin, B.E.; Vreman, H.J.; Stevenson, D.K.; Brien, J.F.; Nakatsu, K.; Maurice, D.H.; Marks, G.S. 1999: Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations Drug Metabolism and Disposition: the Biological Fate of Chemicals 27(10): 1214-1219
Bennett, B.M.; McDonald, B.J.; St James, M.J. 1992: Hepatic cytochrome P-450-mediated activation of rat aortic guanylyl cyclase by glyceryl trinitrate Journal of Pharmacology and Experimental Therapeutics 261(2): 716-723
Gunning, M.; Solomon, R.J.; Epstein, F.H.; Silva, P. 1997: Role of guanylyl cyclase receptors for CNP in salt secretion by shark rectal gland American Journal of Physiology 273(4): R1400-R1406
Hamad, A.M.; Range, S.; Holland, E.; Knox, A.J. 1997: Regulation of cGMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle American Journal of Physiology 273(4): L807-L813
Olson, L.J.; Lowe, D.G.; Drewett, J.G. 1996: Novel natriuretic peptide receptor/guanylyl cyclase A-selective agonist inhibits angiotensin II- and forskolin-evoked aldosterone synthesis in a human zona glomerulosa cell line Molecular Pharmacology 50(2): 430-435
Laurenza, A.; Khandelwal, Y.; De Souza, N.J.; Rupp, R.H.; Metzger, H.; Seamon, K.B. 1987: Stimulation of adenylate cyclase by water-soluble analogues of forskolin Molecular Pharmacology 32(1): 133-139
Sulakhe, S.J.; Sulakhe, P.V. 1976: Properties of membrane-bound and soluble guanylate cyclase of cardiac and skeletal muscle Recent Advances in Studies on Cardiac Structure and Metabolism 11: 257-263
Rambotti, M.G.; Mariucci, G.; Tantucci, M.; Ambrosini, M.V. 2006: Ultracytochemical demonstration of soluble guanylate cyclase activation in rat aorta by NCX4016, a NO-releasing aspirin derivative Journal of Submicroscopic Cytology and Pathology 38(2-3): 149-154
Busygina, O.G.; Belushkina, N.N.; Grigor'ev, N.B.; Severina, I.S. 1995: A new activator of soluble guanylate cyclase generated by nitric oxide and having antihypertensive and anti-aggregation properties Biokhimiia 60(9): 1460-1467
Severina, I.S.; Bussygina, O.G.; Piatakova, N.V. 2000: The activation of soluble guanylate cyclase by new NO donors as the basis of a directed search for new efficacious vasodilators and antiaggregants Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 4: 25-30
Ignarro, L.J. 1989: Heme-dependent activation of soluble guanylate cyclase by nitric oxide: regulation of enzyme activity by porphyrins and metalloporphyrins Seminars in Hematology 26(1): 63-76
Papapetropoulos, A.; Marczin, N.; Mora, G.; Milici, A.; Murad, F.; Catravas, J.D. 1995: Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA, and protein levels by cAMP-elevating agents Hypertension 26(4): 696-704
Sraer, J.D.; Wolff, M.; Delarue, F.; Sraer, J. 1979: Adenylate cyclase and guanylate cyclase activity in the isolated kidney glomerulus of the rat Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 173(2): 445-452
Zadrozna-Sliwka, B.; Bolanowski, M.; Jawiarczyk, A.; Kaluzny, M.; Syrycka, J. 2008: The role of cyclase activating (CAP) and cyclase inhibiting (CIP) parathormone fractions in the assessment of bone metabolism disturbances in women with hyperprolactinemia of various origin Neuro Endocrinology Letters 29(1): 178-184
Cech, S.Y.; Maguire, M.E. 1982: Magnesium regulation of the beta-receptor-adenylate cyclase complex. I. Effects of manganese on receptor binding and cyclase activation Molecular Pharmacology 22(2): 267-273
Northup, J.K.; Mansour, T.E. 1978: Adenylate cyclase from Fasciola hepatica. 1. Ligand specificity of adenylate cyclase-coupled serotonin receptors Molecular Pharmacology 14(5): 804-819
Coffey, R.G.; Davis, J.S.; Djeu, J.Y. 1988: Stimulation of guanylate cyclase activity and reduction of adenylate cyclase activity by granulocyte-macrophage colony-stimulating factor in human blood neutrophils Journal of Immunology 140(8): 2695-2701
Nishimura, T.; Yamashita, H.; Uyama, M. 1984: Localization of adenylate cyclase in the rabbit ciliary epithelium, cytochemical proof. 2. Localization of adenylate cyclase binding to beta-receptor Nippon Ganka Gakkai Zasshi 88(8): 1157-1165
Sawada, S.; Sugai, S.; Iijima, S.; Takei, M.; Paredes, E.; Hayama, T.; Nishinarita, S.; Hosokawa, Y.; Horie, T.; Obara, T. 1992: Increased soluble CD4 and decreased soluble CD8 molecules in patients with Sjögren's syndrome American Journal of Medicine 92(2): 134-140